Also in June, Corning Life Sciences entered into collaboration with TAP Biosystems to develop an automated system that handles up to four of Corning’s Hyperstack®-120 cell culture vessels simultaneously. This provides better control and more consistent results for high-throughput bioprocessing at a lower cost, Dr. Elgen notes.
Corning’s Hyperstack cell culture vessels “use our injection molding fabrication system to create a space to grow cells in high density within a small footprint,” he explains.
Compared to other stacked-plate products, the multilayered, gas-permeable film technology delivers more cells per volume, he continues, adding that cells grow with less variability on the expanded surface area, saving labor and space costs.
Hyperstack cell culture vessels, which are also available as closed systems, can be used for cell-line development, seeding, and manufacturing in bioprocessing systems.
All types of cells need nutrients to grow, and Corning Life Sciences expanded its product offering to include the cellgro® brand of cell culture media and molecular biology reagents for tissue and cell culture applications when it acquired Mediatech at the end of last year.
“Corning has a strong footprint in cell culture vessels, so acquiring Mediatech was a natural step forward,” says Dr. Eglen. The acquisition expands product offerings in off-the-shelf or fully customized beginning-to-end cell culture workflow solutions for upstream and downstream cell culture.
The product line, now sold as Corning cellgro, improves efficiencies and produces more reliable, consistent results, according to Dr. Eglen. Corning cellgro products include culture media, basal salt solutions, antibiotics, reagents, sera, and flexible packaging systems.
Combined with Corning’s disposable vessels and specialized surfaces, the cell culture media products form a comprehensive portfolio for cell culture growth, scale-up, sample preparation, separation, and harvesting, maintains Dr. Eglen.
“The combination of Corning’s Hyperstack vessels, closed system solutions, cellgro, and related single-use products play an important role in bioprocessing and scale-up operations,” he notes.
The acquisition of France-based Plastiques Gosselin added a range of consumables for microbiology and quality control testing. Gosselin’s products include Petri dishes, inoculating loops, dippers, containers, and disposable bags. These diversified consumables serve multiple industry segments, such as food, beverage, and environmental testing laboratories.
Currently undergoing regulatory approval is the agreement to acquire the Discovery Labware unit from Becton Dickinson. When complete, the acquisition will expand offerings in drug discovery tools, bioprocess solutions, and laboratory research instruments.
Corning Life Sciences will obtain four main product platforms from Discovery Labware—plastic consumables, including tubes, pipettes, Petri dishes, tissue culture dishes, and flasks; cell-based assays and cell cultureware; liquid-handling products; and ADME research.
“We expect the deal to close by the end of the year,” says Dr. Eglen.
With a keen interest in emerging countries, Corning Life Sciences recently opened a manufacturing and distribution center in Wujiang, China.
“We see China as an important part of our growth strategy,” points out Dr. Eglen, and the Wujiang facility “helps us capitalize on the growth of biotechnology and drug discovery there.”